Optomed Plc         Stock Exchange Release    6 August 2021 at 13, Helsinki

Change in Optomed's holding of treasury shares

Optomed has conveyed 2,461 treasury shares to the members of the Board of Directors as a part of the Board members' annual remuneration in accordance with the decision of the Annual General Meeting 2021. The amount of shares is based on the monthly remuneration decided by the Annual General Meeting and Optomed's value weighted average share price on 4 August 2021.

Furthermore, a total of 143,250 of shares have been subscribed for under the Company's stock option plans 2015, 2017, 2017B, 2018C and 2019A and Optomed has used treasury shares for the share subscriptions. The subscribed shares will be delivered to the subscribers on 6 August 2021.

                                                                                             
The total amount of treasury shares is now 463 967.

Optomed Plc
 

Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.